BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17318859)

  • 1. Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation.
    Rosenau J; Hooman N; Hadem J; Rifai K; Bahr MJ; Philipp G; Tillmann HL; Klempnauer J; Strassburg CP; Manns MP
    Liver Transpl; 2007 Mar; 13(3):367-73. PubMed ID: 17318859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to an experimental HBV vaccine permits withdrawal of HBIg prophylaxis in fulminant and selected chronic HBV-infected liver graft recipients.
    Stärkel P; Stoffel M; Lerut J; Horsmans Y
    Liver Transpl; 2005 Oct; 11(10):1228-34. PubMed ID: 16184571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus immunization with an adjuvant containing vaccine after liver transplantation for hepatitis B-related disease: failure of humoral and cellular immune response.
    Rosenau J; Hooman N; Rifai K; Solga T; Tillmann HL; Grzegowski E; Nashan B; Klempnauer J; Strassburg CP; Wedemeyer H; Manns MP
    Transpl Int; 2006 Oct; 19(10):828-33. PubMed ID: 16961775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody to hepatitis B surface antigen trough levels and half-lives do not differ after intravenous and intramuscular hepatitis B immunoglobulin administration after liver transplantation.
    Hooman N; Rifai K; Hadem J; Vaske B; Philipp G; Priess A; Klempnauer J; Tillmann HL; Manns MP; Rosenau J
    Liver Transpl; 2008 Apr; 14(4):435-42. PubMed ID: 18383078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis.
    Angelico M; Di Paolo D; Trinito MO; Petrolati A; Araco A; Zazza S; Lionetti R; Casciani CU; Tisone G
    Hepatology; 2002 Jan; 35(1):176-81. PubMed ID: 11786974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease.
    Bienzle U; Günther M; Neuhaus R; Vandepapeliere P; Vollmar J; Lun A; Neuhaus P
    Hepatology; 2003 Oct; 38(4):811-9. PubMed ID: 14512868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration.
    Rosenau J; Kreutz T; Kujawa M; Bahr MJ; Rifai K; Hooman N; Finger A; Michel G; Nashan B; Kuse ER; Klempnauer J; Tillmann HL; Manns MP
    J Hepatol; 2007 Apr; 46(4):635-44. PubMed ID: 17316869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of hepatitis B vaccine combined with two-dose hepatitis B immunoglobulin on infants born to HBsAg-positive mothers.
    Zou H; Chen Y; Duan Z; Zhang H
    PLoS One; 2011; 6(10):e26748. PubMed ID: 22053208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term protection against hepatitis B in pediatric liver recipients can be achieved effectively with vaccination after transplantation.
    Kwon CH; Suh KS; Yi NJ; Chang SH; Cho YB; Cho JY; Lee HJ; Seo JK; Lee KU
    Pediatr Transplant; 2006 Jun; 10(4):479-86. PubMed ID: 16712607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation.
    Sánchez-Fueyo A; Rimola A; Grande L; Costa J; Mas A; Navasa M; Cirera I; Sánchez-Tapias JM; Rodés J
    Hepatology; 2000 Feb; 31(2):496-501. PubMed ID: 10655276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimization of anti-hepatitis B surface antigen immunoglobulins for prophylaxis of hepatitis B viral recurrence in the first month after liver transplantation: the meaning of HBsAg quantitative level at the time of transplant.
    Tandoi F; Nada E; Pittaluga F; Fop F; Lupo F; Romagnoli R; Salizzoni M
    Transplant Proc; 2014 Sep; 46(7):2308-11. PubMed ID: 25242775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose hepatitis B immune globulin and higher-dose lamivudine combination to prevent hepatitis B virus recurrence after liver transplantation.
    Karasu Z; Ozacar T; Akyildiz M; Demirbas T; Arikan C; Kobat A; Akarca U; Ersoz G; Gunsar F; Batur Y; Kilic M; Tokat Y
    Antivir Ther; 2004 Dec; 9(6):921-7. PubMed ID: 15651751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and efficacy of intravenous or intramuscular hepatitis B immunoglobulins in prophylaxis of hepatitis B after liver transplantation.
    Marzano A; Marengo A; Andreone P; Volpes R; Canova D; Cursaro C; Riili A; Fiorentino B; Bacci M; Guazzini S; Burra P
    Minerva Med; 2010 Dec; 101(6):373-83. PubMed ID: 21196896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with an adjuvant hepatitis B vaccine in liver transplant recipients: antibody decline and booster vaccination with conventional vaccine.
    Günther M; Neuhaus R; Bauer T; Jilg W; Holtz JA; Bienzle U
    Liver Transpl; 2006 Feb; 12(2):316-9. PubMed ID: 16447191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.
    Han SH; Ofman J; Holt C; King K; Kunder G; Chen P; Dawson S; Goldstein L; Yersiz H; Farmer DG; Ghobrial RM; Busuttil RW; Martin P
    Liver Transpl; 2000 Nov; 6(6):741-8. PubMed ID: 11084061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin.
    Terrault NA; Zhou S; Combs C; Hahn JA; Lake JR; Roberts JP; Ascher NL; Wright TL
    Hepatology; 1996 Dec; 24(6):1327-33. PubMed ID: 8938155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active immunization for prevention of De novo hepatitis B virus infection after adult living donor liver transplantation with a hepatitis B core antigen-positive graft.
    Wang SH; Loh PY; Lin TL; Lin LM; Li WF; Lin YH; Lin CC; Chen CL
    Liver Transpl; 2017 Oct; 23(10):1266-1272. PubMed ID: 28691231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year vaccination against hepatitis B virus with a MPL-vaccine in liver transplant patients for HBV-related cirrhosis.
    Di Paolo D; Lenci I; Cerocchi C; Tariciotti L; Monaco A; Brega A; Lotti L; Tisone G; Angelico M
    Transpl Int; 2010 Nov; 23(11):1105-12. PubMed ID: 20492620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B.
    Lo CM; Liu CL; Chan SC; Lau GK; Fan ST
    J Hepatol; 2005 Aug; 43(2):283-7. PubMed ID: 15964658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus vaccine switch program for prevention of de novo hepatitis B virus infection in pediatric patients.
    Park JB; Kwon CH; Lee KW; Choi GS; Kim DJ; Seo JM; Kim SJ; Joh JW; Lee SK
    Transpl Int; 2008 Apr; 21(4):346-52. PubMed ID: 18208419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.